Daxor Corp. Approves Annual Dividend, Payable on December 29, 2016; Names Michael Feldschuh as President and Chief Executive Officer on Permanent Basis
Michael Feldschuh, who has been Acting President and Chief Executive Officer for the company, has been named to the post on a permanent basis. Dr. Joseph Feldschuh has assumed the position of Chief Medical Officer while on temporary leave.